This site is intended for health professionals only
Sunday 26 May 2019
Share |

Ebola victims include pharmacy professionals

Community pharmacy professionals are among the Ebola fatalities.
West Africa

Community pharmacy professionals are among the Ebola fatalities of health care workers in Sierra Leone, although reported numbers vary.
A pharmacist source on the ground earlier this week told cite the International Pharmaceutical Federation (FIP) that one pharmacist and four pharmacy technicians have died, all five from the community pharmacy sector. However, another report from the Pharmaceutical Society of Sierra Leone is that there has been one pharmacy Ebola death – a pharmacy technician who was practising in a community pharmacy in Kenema, Sierra Leone, one of the disease epicentres.
The outbreak of the virus in West Africa was declared an ‘extraordinary’ public health emergency by the World Health Organization (WHO) on the 7 August 2014, requiring a coordinated international response to stop its spread.

Pharmacies inundated
Pharmacies in Liberia have been inundated with people wanting to buy essential medicines after a second outbreak of the virus. Many are reluctant to go to hospitals and clinics because several health workers have become infected. Pharmacists in affected and neighbouring countries have been preparing for the spread of the virus.
The Liberia Medicine and Health Regulatory Authority is now directing an ongoing awareness campaign at pharmacists and dispensers across the country. The Pharmaceutical Society of Ghana has warned pharmacists to be alert for Ebola symptoms and Sierra Leone’s Ministry of Health held a pharmacy ‘ensitisation meeting’ in collaboration with the country’s pharmacy board and the pharmaceutical society. Training programmes based on WHO guidelines have been conducted in Sierra Leone. However, it has also been reported to FIP that some pharmaceutical outlets where the outbreak is seriously affecting health care workers have closed.

Educate about sanitising measures
A spokesman from the Pharmaceutical Society of Sierra Leone said that activities to educate pharmacy professionals on basic preventive measures, identification and prompt referral of suspected cases are being undertaken. Public campaigns are also being run on the proper use of disinfectants and hand sanitisers. “We currently have a lot of chlorine and chlorine-containing products … being used by the general public as a means of antisepsis. We realised that the general public was wrongly mixing the chlorine and thereby exposing themselves to the toxic effects of the chlorine or having too little of the chlorine in the mixture, which mitigates against its proper antiseptic functions. So we engaged all pharmacy professionals and pharmacy business owners on how to properly use the chlorine-containing preparations and other disinfectants against the virus. Currently we have teams going around towns and teaching the general public on how to properly mix the chlorine for public hand washing,” he said.
“Pharmacists, as the first point of care for many people, have an important role to play in such emergencies, not only in terms of vigilance but also on a wider scale such as raising awareness and knowledge and providing advice to travellers,” says Luc Besançon, CEO and general secretary of FIP.
WHO resources on Ebola include a fact sheet containing essential information on the disease, transmission and prevention, frequently asked questions and advice for travellers. Salient points include:

  • The incubation period of Ebola virus disease (EBV) varies between 2 and 21 days.
  • Direct contact with infected persons or their body fluids/secretions (considered the principal mode of transmission) should be avoided. There is no risk of transmission during the incubation period and low risk in the early phase of symptoms.
  • Risk of tourists and businessmen/women returning from affected areas in a country becoming infected with Ebola virus is ‘extremely low’. The WHO also describes risks for other groups including those visiting friends and relatives and health care workers.
  • Returning visitors from affected areas should be alert to symptoms such as sudden onset of fever, weakness, muscle pain, headache and sore throat (early stage) within 3 weeks of leaving the area. Later stage symptoms include vomiting, diarrhoea, rash, impaired liver and kidney function and internal and external bleeding.       
  • Effective disinfectant is a dilution of sodium hypochlorite at 0.05% or 500ppm available chlorine with a recommended contact time of 30 minutes.
  • When within 1 metre of patients with EBV, health care workers should wear face protection (face shield or mask plus goggles), a long-sleeved gown and gloves.

FIP is also drawing attention to WHO guidance specifically for healthcare professionals. “All pharmacists, not only those in affected areas, could potentially play a part in the coordinated international response to stop the spread of this virus,” Mr Besançon said.
More information is available at www.who.int/csr/disease/ebola/en/. Source: International Pharmaceutical Federation (FIP).

Ads by Google

You are leaving www.nursinginpractice.com

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?

Close

Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.


GET INVOLVED: SIGN OUR E-PETITION

Close

Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher




http://www.facebook.com/NursinginPracticeMagazine